Clinical Oncology - Issue 3/2023
Editorial
Review
Z. Adam, L. Pour, D. Zeman, M. Krejčí, I. Boichuk, M. Krejčí, M. Štork, V. Sandecká, Z. Král
P. Bician, M. Mego
M. Hovhannisyan, P. Kleiblová, P. Nehasil, J. Soukupová, P. Zemánková, Z. Kleibl, M. Janatová
H. Votavová, Z. Lenertová, T. Votava, M. Beličková
Original Articles
M. Bednaříková, J. Hausnerová, L. Minář, R. Taslerová, P. Vinklerová, L. Ehrlichová, J. Trizuljak, I. Blaháková, D. Princ, K. Matulová, P. Ovesná, O. Slabý, V. Weinberger
Z. Majerčíková, K. Dibdiaková, M. Galanda, T. Galanda, R. Richterová, B. Kolarovszki, P. Račay, J. Hatok
Case Report
K. Skřivanová, Jr K. Smetana, T. Korbička, J. Hudec, M. Jaborník, V. Procházka
L. Sukrisman, W. Rajabto, A. S. Harahap, E. S. D. E. Fanggidae, M. F. Ham, D. Priantono
Clinical Oncology
![Issue 3](https://www.prolekare.cz/media/cache/resolve/journal_issue/media/image_pdf/5eb03a7489f07407fbe0eb1a59c7ac9f.jpg)
2023 Issue 3
Most read in this issue
- Waldenström’s macroglobulinemia – clinical symptoms and review of therapy yesterday, today and tomorrow
- Molecular testing of endometrial carcinoma in real-world clinical practice
- Polygenic risk score (PRS) and its potential for breast cancer risk stratification
- Hypoplastic form of myelodysplastic neoplasm